^
Association details:
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Esophageal and Esophagogastric Junction Cancers: Preferred Regimens…Preferred Regimens…Capecitabine and cisplatin.